CITIGROUP INC - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 52 filers reported holding HAEMONETICS CORP MASS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$440,690
+191.0%
508,000
+185.4%
0.00%
Q2 2023$151,460
+138.0%
178,000
+137.3%
0.00%
Q1 2023$63,636
-41.6%
75,000
-45.3%
0.00%
Q3 2022$109,000
-94.4%
137,000
-94.5%
0.00%
-100.0%
Q2 2022$1,938,000
+17518.2%
2,477,000
+18953.8%
0.00%
Q1 2022$11,00013,0000.00%
Other shareholders
HAEMONETICS CORP MASS shareholders Q3 2023
NameSharesValueWeighting ↓
Wellesley Asset Management 48,416$41,563,0002.83%
HPS Investment Partners, LLC 5,419$4,567,0001.76%
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,169,0000.83%
ADVENT CAPITAL MANAGEMENT /DE/ 48,979,000$41,243,0000.66%
Aequim Alternative Investments LP 20,500,000$17,276,0000.46%
Kohlberg Kravis Roberts & Co. L.P. 45,394,000$38,255,0000.35%
Quaero Capital S.A. 900,000$757,0000.26%
OAKTREE CAPITAL MANAGEMENT LP 21,614,000$18,214,0000.19%
Brandywine Global Investment Management, LLC 29,515,000$24,873,0000.18%
AVIVA PLC 38,300,000$32,126,0000.16%
View complete list of HAEMONETICS CORP MASS shareholders